InterAx Biotech
Headquarters
deliveryLAB, 5234 Villigen, Switzerland
Industry
HealthTech
Website
About us
InterAx Biotech AG is a spinoff from ETH Zurich and the Paul Scherrer Institute. InterAx has built a unique drug discovery platform for identification of superior drug candidates. This technology allows for the integration of both, experimental and computational pharmacology, and is able to predict in vivo effects of drug candidates by analyzing complex experimental in vitro data sets.
Organization size
11-50 employees
Wanted occupations
Wanted field of studies
Funding stage
Private